Your browser doesn't support javascript.
loading
Enhanced antibiotic resistance development from fluoroquinolone persisters after a single exposure to antibiotic.
Barrett, Theresa C; Mok, Wendy W K; Murawski, Allison M; Brynildsen, Mark P.
Afiliação
  • Barrett TC; Department of Molecular Biology, Princeton University, Princeton, NJ, 08544, USA.
  • Mok WWK; Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, 08854, USA.
  • Murawski AM; Department of Chemical and Biological Engineering, Princeton University, Princeton, NJ, 08544, USA.
  • Brynildsen MP; Department of Molecular Biology and Biophysics, UConn Health, Farmington, CT, 06032-3305, USA.
Nat Commun ; 10(1): 1177, 2019 03 12.
Article em En | MEDLINE | ID: mdl-30862812
ABSTRACT
Bacterial persisters are able to tolerate high levels of antibiotics and give rise to new populations. Persister tolerance is generally attributed to minimally active cellular processes that prevent antibiotic-induced damage, which has led to the supposition that persister offspring give rise to antibiotic-resistant mutants at comparable rates to normal cells. Using time-lapse microscopy to monitor Escherichia coli populations following ofloxacin treatment, we find that persisters filament extensively and induce impressive SOS responses before returning to a normal appearance. Further, populations derived from fluoroquinolone persisters contain significantly greater quantities of antibiotic-resistant mutants than those from untreated controls. We confirm that resistance is heritable and that the enhancement requires RecA, SOS induction, an opportunity to recover from treatment, and the involvement of error-prone DNA polymerase V (UmuDC). These findings show that fluoroquinolones damage DNA in persisters and that the ensuing SOS response accelerates the development of antibiotic resistance from these survivors.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resposta SOS em Genética / Ofloxacino / Farmacorresistência Bacteriana / Escherichia coli / Antibacterianos Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resposta SOS em Genética / Ofloxacino / Farmacorresistência Bacteriana / Escherichia coli / Antibacterianos Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos